Tempo differito
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,074 USD | +5,33% | +8,33% | +55,25% |
Attività
Numero di dipendenti: 28
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
John Celebi
CEO | Chief Executive Officer | 52 | 01/02/18 |
Erin Colgan
DFI | Director of Finance/CFO | 43 | 01/07/20 |
Chief Tech/Sci/R&D Officer | 51 | 01/09/19 | |
Alice Drumheller
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/18 |
Michael Biega
IRC | Investor Relations Contact | - | 01/06/22 |
Stephanie Krebs
PRN | Corporate Officer/Principal | - | 01/11 |
General Counsel | - | 01/07/22 | |
Bao Le
LAW | General Counsel | - | 01/06/21 |
Corporate Officer/Principal | 44 | 01/06/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
William Ringo
CHM | Chairman | 78 | 08/03/22 |
John Celebi
CEO | Chief Executive Officer | 52 | 01/02/18 |
Bob Holmen
BRD | Director/Board Member | 60 | 01/01/17 |
Thomas Ricks
BRD | Director/Board Member | 70 | 01/01/15 |
Deneen Vojta
BRD | Director/Board Member | 59 | 29/01/20 |
James Peyer
BRD | Director/Board Member | 37 | 01/01/20 |
Kristian Humer
BRD | Director/Board Member | 49 | 30/07/21 |
Jessie English
BRD | Director/Board Member | 60 | 01/04/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 25 070 980 | 16 384 834 ( 65,35 %) | 0 | 65,35 % |
Coordinate società
Sensei Biotherapeutics, Inc.
1405 Research Boulevard` Suite 125
20850, Rockville
+240 243 8000
http://senseibio.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+55,25% | 25,57 Mln | |
-2,66% | 102 Mrd | |
+2,33% | 96,09 Mrd | |
+2,13% | 22,28 Mrd | |
-16,84% | 21,4 Mrd | |
-8,79% | 18,14 Mrd | |
-39,98% | 17,02 Mrd | |
-13,80% | 16,09 Mrd | |
+6,45% | 13,83 Mrd | |
+32,53% | 11,97 Mrd |
- Borsa valori
- Azioni
- Azione SNSE
- Società Sensei Biotherapeutics, Inc.